Vivoryon Therapeutics Statistics

Total Valuation

LON:0R3M has a market cap or net worth of GBP 32.79 million. The enterprise value is 24.78 million.

Market Cap	32.79M
Enterprise Value	24.78M

Important Dates

The last earnings date was Tuesday, June 17, 2025.

Earnings Date	Jun 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	26.23M
Shares Outstanding	n/a
Shares Change (YoY)	+3.27%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	21.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	5.03
P/TBV Ratio	5.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.46
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.56

Financial Position

The company has a current ratio of 7.20, with a Debt / Equity ratio of 0.01.

Current Ratio	7.20
Quick Ratio	6.93
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-445.97

Financial Efficiency

Return on equity (ROE) is -120.41% and return on invested capital (ROIC) is -76.38%.

Return on Equity (ROE)	-120.41%
Return on Assets (ROA)	-62.22%
Return on Invested Capital (ROIC)	-76.38%
Return on Capital Employed (ROCE)	-212.05%
Revenue Per Employee	n/a
Profits Per Employee	-1.21M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.40% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-24.40%
50-Day Moving Average	1.66
200-Day Moving Average	1.96
Relative Strength Index (RSI)	33.48
Average Volume (20 Days)	544

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.33M
Pretax Income	-17.01M
Net Income	-17.01M
EBITDA	-17.26M
EBIT	-17.33M
Earnings Per Share (EPS)	-0.65

Full Income Statement

Balance Sheet

The company has 7.76 million in cash and 84,351 in debt, giving a net cash position of 7.68 million.

Cash & Cash Equivalents	7.76M
Total Debt	84,351
Net Cash	7.68M
Net Cash Per Share	n/a
Equity (Book Value)	6.52M
Book Value Per Share	0.25
Working Capital	7.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.86 million and capital expenditures -1,654, giving a free cash flow of -15.86 million.

Operating Cash Flow	-15.86M
Capital Expenditures	-1,654
Free Cash Flow	-15.86M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0R3M does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.27%
Shareholder Yield	n/a
Earnings Yield	-51.88%
FCF Yield	-48.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1